Parallel BioUsing the immune system to cure disease

Parallel Bio: Revolutionizing Drug Discovery with Organoids and AI

Introduction

Parallel Bio is pioneering the future of pharmaceutical development by leveraging immune organoids and artificial intelligence (AI) to design drugs that work in humans from the start. Our innovative approach eliminates the need for traditional clinical trials, offering a faster, safer, and more effective pathway to therapeutic discovery.

Key Features

• Immune Organoids: Functioning in-vitro replicas of human lymph nodes.
• AI-Powered Drug Discovery: Utilizes proprietary immune data to drive drug discovery.
• High-Throughput Automation: Scalable technology for massive data generation.
• Ethical Development: Zero-risk, fully-ethical development of therapies.
• FDA-Ready: Aligns with regulatory push for innovative drug development methods.

Use Cases

• Trial-in-a-Dish: Predict drug safety across a diverse population.
• Disease Modeling: Create realistic, patient-matched models of disease.
• Target Discovery: Identify novel causes and targets for new drug programs.

Pricing

Our pricing model is tailored to meet the needs of pharmaceutical and biotech companies, offering scalable solutions that reduce the cost and time associated with traditional drug development. Contact us for detailed pricing information.

Teams

Parallel Bio collaborates with the world's leading pharma and biotech companies to transform immunotherapy discovery. Our team of experts is dedicated to pushing the boundaries of what is possible, ensuring that more effective therapies reach patients faster and more efficiently.

Join us on our mission to create a healthier world through innovative drug discovery.